MedTrace Logo

Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section

NCT03775655 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-01-15

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness of low dose scheme with dexmedetomidine as an adjuvant. Taking in consideration optimum intraoperative surgical conditions, best post-operative pain free experience, and more stable hemodynamic.

Conditions

  • Cesarean Section
  • Spinal Anesthesia
  • Dexmedetomidine

Interventions

DRUG

Dexmedetomidine

10μg dexmedetomidine will be added to the injectate to be injected intrathecally

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • Mamdoh Lotfy, Prof. Dr. · Faculty of Medicine - Menoufia University

  • Safaa M Helal, Prof. Dr. · Faculty of Medicine - Menoufia University

  • Wesameldin A Soltan, Dr. · Faculty of Medicine - Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-01-10
Completion
2019-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03775655 on ClinicalTrials.gov